A Winning Methodology: Key Criteria for Success in Launching an NGS assay
Read more
Blog
On October 10, 2024 | By Cates Mallaney
News
On October 8, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Diagnostica Longwood Partner to Revolutionize Access to Precision Genomics for Patients in Spain and Portugal
Read more
Video
On October 3, 2024 | By The Velsera Clinical and Compliance Team
Optimizing RCM with 2024 CPT Code Updates
Read more
Video
On October 2, 2024 | By The Velsera Clinical and Compliance Team
The Variant Interpretation for Cancer Consortium (VICC) – FDA LDT Discussion
Read more
News
On September 16, 2024 | By The Velsera Clinical and Compliance Team
Velsera Technology Paves the Way for Advanced Cancer Diagnostics with FDA Approval of Illumina TruSight™ Oncology Comprehensive IVD
Read more
Blog
On September 12, 2024 | By Liam Scott
A Story of Support: Our Innovation Improves Your Results
Read more
Video
On September 10, 2024 | By The Velsera Clinical and Compliance Team
Tackling Complexity in Oncology Biomarker Interpretation with CGW Plus
Read more
Blog
On August 23, 2024 | By Lea Lenhardt Ackovic
STAARpipeline apps: Enhancing Rare Variant Analysis in Whole-Genome Sequencing Studies
Read more
Video
On August 10, 2024 | By The Velsera Clinical and Compliance Team
RHEO in Action: A snapshot of innovation
Read more
Video
On August 1, 2024 | By The Velsera Clinical and Compliance Team
Expanding Your Research Horizons: Single Cell and Spatial Transcriptomics Capabilities in Biomedical Research
Read more
Blog
On July 23, 2024 | By The Velsera Clinical and Compliance Team
Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2
Read more
Blog
On July 18, 2024 | By Julie Furt
Enhancing the Precision Medicine Journey
Read more